// App-Quantinova.ai

581 : Comparative Analysis of Outcomes Among Patients with Rheumatoid Arthritis Initiating Tofacitinib in Combination with Oral MTX Who Discontinue, Interrupt, or Persist with MTX

Researchers

Presenter

  • Boulos Haraoui

Principal Investigators

  • Jeffrey R. Curtis

  • Timothy Smith

  • John Woolcott

  • David Gruben

  • Christopher W Murray

  • Noriko Iikuni

  • Andrew Koenig

  • James Harnett

Medical Centers

  • Metroplax Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX

  • Institut de Rhumatologie, Montreal, QC, Canada

  • University of Alabama at Birmingham, Birmingham, AL

  • Pfizer Inc, New York, NY

  • Pfizer Inc, Collegeville, PA

  • Pfizer, Groton, CT

Locations

  • United States

  • Canada

Companies

  • Pfizer Inc.

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Tasocitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved